Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.64 |
| ▸ | PKM | P14618 | 2/20 | 0.61 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HTR1B | P28222 | 2/20 | 0.56 |
| ▸ | HTR1D | P28221 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | LTA4H | P09960 | 3/20 | 0.54 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.52 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.52 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.52 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.52 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.52 |
| ▸ | DRD2 | P14416 | 2/20 | 0.50 |
| ▸ | DRD4 | P21917 | 2/20 | 0.50 |
| ▸ | DRD3 | P35462 | 2/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL3997746 | 0.98 | KCNA3 (0.61) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL28279031 | 0.98 | KCNA3 (0.61) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL10711044 | 0.93 | KCNA3 (0.56) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL22297235 | 0.93 | KCNA3 (0.56) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL11134448 | 0.93 | KCNA3 (0.56) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL1535614 | 0.93 | KCNA3 (0.56) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL5897061 | 0.93 | KCNA3 (0.56) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL11696618 | 0.91 | LTA4H (0.68) | KCNA3PKMMAPTRAB9ALTA4H | |
| SCHEMBL7244326 | 0.88 | KCNA3 (0.76) | KCNA3PKMTAAR1ALDH1A1RECQL | |
| SCHEMBL3370563 | 0.88 | KCNA3 (0.68) | KCNA3PKMTAAR1ALDH1A1RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119833747-A | Ether electrolyte, lithium secondary battery and electric equipment | 重庆弗迪电池研究院有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-114171766-B | High efficiency zinc-iodine adsorption assisted flow battery with low cost thin film | 香港中文大学 | 2024-01-16 | — | — | CN | claimed |
| CN-117099234-A | Flame retardant for battery electrolyte | 雅宝公司 | 2023-11-21 | — | — | CN | claimed |
| CN-116053456-A | High-voltage lithium cobaltate battery and preparation method thereof | 洛阳大生新能源开发有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-115215733-A | Preparation method of 2-bromo-3-fluorophenol | 西安拓超生物科技有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-115149099-A | Electrolyte and lithium ion battery containing same | 湖北亿纬动力有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-114171766-A | High-efficiency zinc-iodine adsorption auxiliary flow battery with low-cost film | 香港中文大学 | 2022-03-11 | — | — | CN | claimed |
| CN-113620945-A | RET inhibitor, pharmaceutical composition thereof and application thereof in medicines | 广东东阳光药业有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-111816935-A | Method of charging secondary lithium metal batteries to reactivate dead lithium with redox shuttle additives and battery control system incorporating the method | 麻省固能控股有限公司 | 2020-10-23 | — | — | CN | claimed |
| EP-2951179-B1 | SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS | MERCK PATENT GMBH (DE) | 2020-03-11 | — | — | EP | claimed |
| US-6288262-B2 | REACTION OF PHENOL WITH 2-CHLOROETHYL METHYL ETHER WITHOUT POLAR SOLVENT | BAYER AKTIENGESELLSCHAFT (DE) | 2001-09-11 | — | — | US | claimed |
| EP-1123913-A2 | Process for preparing 2-methoxyethoxybenzenes and new 2-methoxyethoxybenzyl cyanides | BAYER AG (DE) | 2001-08-16 | — | — | EP | claimed |
| US-20010014697-A1 | Process for the preparation of 2-methoxyethoxy-benzenes and novel 2-methoxyethoxy-benzyl cyanides | LANXESS DEUTSCHLAND GMBH (DE) | 2001-08-16 | — | — | US | claimed |
| CN-1242699-A | Oxidation dyeing composition for keratin fibres and dyeing method using said composition | OREAL (FR) | 2000-01-26 | — | — | CN | claimed |
| US-5840974-A | Metalloproteinase inhibitors | BRITISCH BIOTECH PHARMACEUTICALS, LTD. (GB) | 1998-11-24 | — | — | US | claimed |
| CN-1142255-A | Multicomponent system for modifying decomposing or bleaching lignin, lignin-containing materials or similar substances and method of using this system | LIGNOZYM GMBH (DE) | 1997-02-05 | — | — | CN | claimed |
| CN-1120345-A | Improved floor paint stripper composition and stripping method | MINNESOTA MINING & MFG (US) | 1996-04-10 | — | — | CN | claimed |
| US-5135932-A | 2-HYDROXYPROPYLAMINO-ALKYL-BENZIMIDAZOLY-5-YL DERIVATIVES AND THEIR USE IN THE TREATMENT OF HEART DISEASE | DR. KARL THOMAE GMBH (DE) | 1992-08-04 | — | — | US | claimed |
| EP-0400519-A1 | 2-Hydroxy-n-propylamines, medicaments containing these compounds and method for preparing them | Dr. Karl Thomae GmbH (DE) | 1990-12-05 | — | — | EP | claimed |
| US-4225706-A | Polychalcogen ester of cephem compound, process for preparing the same and method for removing the protective group of the same | MEIJI SEIKA KAISHA LTD. (JP) | 1980-09-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014697-A1 | Process for the preparation of 2-methoxyethoxy-benzenes and novel 2-methoxyethoxy-benzyl cyanides | TET2, CYCS, TYR | KCNA3 420/4885PKM 2179/4885TAAR1 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.